Author

Loren Bird

Observed name: L. Bird

Institution: Nationwide Children's Hospital

Observed institutions: Nationwide Children's Hospital, The Ohio State University

OpenAlex ID: A5111656544

Eteplirsen for the treatment of Duchenne muscular dystrophy

2013 · Jerry R. Mendell, Louise R. Rodino‐Klapac, et al. · Annals of Neurology · 820

Eteplirsen for the treatment of duchenne muscular dystrophy. Ann Neurol

2013 · Jerry R. Mendell, Louise R. Rodino Klapac, et al. · 31

2014 · P. Sazani, T. Magee, et al. · Neuromuscular Disorders · 2

Results at 96 Weeks of a Phase IIb Extension Study of the Exon-Skipping Drug Eteplirsen in Patients with Duchenne Muscular Dystrophy (DMD) (S6.002)

2014 · Edward Kaye, Jerry Mendell, et al. · Neurology · 1

P.11.20 Results at 2 years of a phase IIb extension study of the exon-skipping drug eteplirsen in patients with DMD

2013 · J.R. Mendell, L. Rodino-Klapac, et al. · Neuromuscular Disorders · 1

D.O.1 A two-tiered approach to newborn screening for Duchenne muscular dystrophy (DMD) using dried blood spots for sequential CK and DNA analysis

2012 · J.R. Mendell, C. Shilling, et al. · Neuromuscular Disorders · 1

2014 · J.R. Mendell, L. Rodino-Klapac, et al. · Neuromuscular Disorders

Baseline Performance on 6MWT Correlates with Other Functional Outcomes in a Phase IIb Study of Exon-Skipping Antisense Oligonucleotide Eteplirsen for Use in Duchenne Muscular Dystrophy (DMD) (P5.091)

2014 · Jihad Saoud, Jerry Mendell, et al. · Neurology

Safety Profile and Pharmacokinetic Properties of Eteplirsen in the Treatment of Boys with Duchenne Muscular Dystrophy (S6.001)

2014 · Jihad Saoud, Jerry Mendell, et al. · Neurology

Works count: 9

Citation count: 856

H-index: 2

I10-index: 2